Applying prospective tree-temporal scan statistics to genomic surveillance data to detect emerging SARS-CoV-2 variants and salmonellosis clusters in New York City

将前瞻性树状时间扫描统计方法应用于基因组监测数据,以检测纽约市新出现的SARS-CoV-2变异株和沙门氏菌病聚集性病例

阅读:1

Abstract

BACKGROUND: The detection of communicable disease clusters in genomic surveillance data typically involves the application of rule-based signaling criteria, which can be arbitrary. In contrast, scan statistics that are used for spatiotemporal cluster detection can flexibly scan in calendar time, and scan statistics that are used for pharmacovigilance can flexibly scan along hierarchical tree structures that are based on diagnosis codes. METHODS: New York City (NYC) Health Department staff applied tree-temporal scan statistics prospectively to genomic surveillance data with a hierarchical nomenclature for COVID-19 and salmonellosis cases that were diagnosed among NYC residents. We searched weekly for recent case increases at any granularity, from large phylogenetic branches to small groups of indistinguishable isolates. Using free and open-source TreeScan software, we looked for emerging SARS-CoV-2 variants based on Pango lineages during August 2021-November 2023 and emerging clusters of Salmonella isolates based on allele codes during November 2022-November 2023. RESULTS: The SARS-CoV-2 Omicron subvariant EG.5.1 first signaled as locally emerging on 22 June 2023, 7 weeks before the World Health Organization designated it as a variant of interest. During 1 year of salmonellosis analyses, TreeScan detected 15 credible clusters that were worth investigating for common exposures and two data-quality issues for correction. CONCLUSION: A challenge was the maintenance of timely and specific lineage assignments, and a limitation was that genetic distances between tree nodes were not considered. By automatically sifting through genomic data and generating ranked shortlists of nodes with statistically unusual recent case increases, TreeScan assisted in detecting emerging variants and clusters of communicable diseases and in prioritizing them for investigation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。